This bill amends current law to increase the annual allocation of cigarette and other tobacco products tax revenues to the New Jersey Commission on Cancer Research (NJCCR) from $1 million to $10 million. It establishes a dedicated, non-lapsing Cancer Research Fund within the Department of the Treasury, which will serve as the repository for these funds and any additional funds approved by the Department of Health or the NJCCR. The bill mandates that at least $5 million of the fund be allocated for general cancer research and at least $5 million for pediatric cancer research, ensuring a focus on reducing disparities in cancer care among minority and vulnerable communities.

Additionally, the bill repeals the existing lapsing Cancer Research Fund and replaces it with the new non-lapsing, revolving fund. The State Treasurer will act as the custodian of this fund, overseeing all disbursements and ensuring that the funds are invested similarly to other state trust funds. This legislative change aims to enhance the NJCCR's capacity to fund vital cancer research and improve access to high-quality cancer care and treatment for all New Jersey residents.

Statutes affected:
Introduced: 54:40A-37.1, 52:9U-8